SCHEMBL10837645

SCHEMBL10837645

CCN(c1ccncc1)c1ccccc1C(=O)N1CCCCC1

nearest known ligand 0.45

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
▸ HTT P42858 2/20 0.45
▸ KMT2A Q03164 4/20 0.44
▸ ALDH1A1 P00352 4/20 0.44
▸ HSD17B10 Q99714 2/20 0.44
▸ CYP2C9 P11712 1/20 0.44
▸ KDM4E B2RXH2 1/20 0.44
▸ TSHR P16473 3/20 0.43
▸ MEN1 O00255 2/20 0.43
▸ SMN1; SMN2 Q16637 4/20 0.43
▸ ADRA1A P35348 2/20 0.42
▸ ADRA1B P35368 2/20 0.42
▸ ADRA1D P25100 1/20 0.42
▸ LMNA P02545 2/20 0.41
▸ POLB P06746 1/20 0.41
▸ RECQL P46063 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10838466 0.91 HTT (0.43) HTTKMT2AALDH1A1HSD17B10CYP2C9
SCHEMBL10838404 0.86 KMT2A (0.42) HTTKMT2AALDH1A1HSD17B10CYP2C9
SCHEMBL10836959 0.84 HTT (0.48) HTTKMT2AALDH1A1HSD17B10CYP2C9
SCHEMBL10839348 0.78 CDC7 (0.39) HTTKMT2AALDH1A1HSD17B10KDM4E
SCHEMBL10838759 0.75 HTT (0.46) HTTKMT2AALDH1A1KDM4ETSHR
SCHEMBL10987172 0.69 HTT (0.49) HTTKMT2AKDM4ETSHRMEN1
SCHEMBL10720608 0.68 TSHR (0.69) HTTKMT2AALDH1A1KDM4ETSHR
SCHEMBL13905030 0.68 HTT (0.57) HTTKMT2AALDH1A1HSD17B10TSHR
Ofornine SCHEMBL120272 0.68 LMNA (0.62) HTTKMT2AALDH1A1HSD17B10CYP2C9
SCHEMBL29944048 0.68 ALDH1A1 (0.74) KMT2AALDH1A1KDM4ETSHRMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-4610991-A Antihypertensive pyridylaminobenzamide compounds STERLING DRUG INC. (US) 1986-09-09 — — US disclosed
EP-0098951-A2 Aminobenzamide derivatives and preparation thereof STERLING DRUG INC. (US) 1984-01-25 — — EP disclosed
Send feedback